Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
1.760
+0.060
(+3.53%)
Streaming Delayed Price
Updated: 1:37 PM EDT, Jul 30, 2025
Add to My Watchlist
All News about Inhibikase Therapeutics, Inc. - Common Stock


























Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.